Pharma & Healthcare
Global Vaccine Adjuvants Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 198572
- Pages: 98
- Figures: 91
- Views: 23
The global Vaccine Adjuvants market size was US$ 682 million in 2024 and is forecast to a readjusted size of US$ 1213 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
The global Vaccine Adjuvants market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus
By Type: (Dominant Segment vs High-Margin Innovation)
Emulsion Adjuvants
Mineral Adjuvants
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Human Vaccine
Veterinary Vaccine
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., GSK in Europe)
- Emerging Product Trends: Emulsion Adjuvants adoption vs. Mineral Adjuvants premiumization
- Demand-Side Dynamics: Human Vaccine growth in China vs. Veterinary Vaccine potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Vaccine Adjuvants market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mineral Adjuvants in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Veterinary Vaccine in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Emulsion Adjuvants dominance in Europe vs. Mineral Adjuvants demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
The global Vaccine Adjuvants market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus
By Type: (Dominant Segment vs High-Margin Innovation)
Emulsion Adjuvants
Mineral Adjuvants
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Human Vaccine
Veterinary Vaccine
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., GSK in Europe)
- Emerging Product Trends: Emulsion Adjuvants adoption vs. Mineral Adjuvants premiumization
- Demand-Side Dynamics: Human Vaccine growth in China vs. Veterinary Vaccine potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Vaccine Adjuvants market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mineral Adjuvants in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Veterinary Vaccine in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Emulsion Adjuvants dominance in Europe vs. Mineral Adjuvants demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Vaccine Adjuvants Product Scope
1.2 Vaccine Adjuvants by Type
1.2.1 Global Vaccine Adjuvants Sales by Type (2020 & 2024 & 2031)
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Vaccine Adjuvants by Application
1.3.1 Global Vaccine Adjuvants Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Global Vaccine Adjuvants Market Estimates and Forecasts (2020-2031)
1.4.1 Global Vaccine Adjuvants Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Vaccine Adjuvants Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Vaccine Adjuvants Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Vaccine Adjuvants Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Vaccine Adjuvants Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Vaccine Adjuvants Sales Market Share by Region (2020-2025)
2.2.2 Global Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
2.3 Global Vaccine Adjuvants Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Vaccine Adjuvants Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Vaccine Adjuvants Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Vaccine Adjuvants Market Size and Prospective (2020-2031)
2.4.2 Europe Vaccine Adjuvants Market Size and Prospective (2020-2031)
2.4.3 China Vaccine Adjuvants Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Vaccine Adjuvants Historic Market Review by Type (2020-2025)
3.1.1 Global Vaccine Adjuvants Sales by Type (2020-2025)
3.1.2 Global Vaccine Adjuvants Revenue by Type (2020-2025)
3.1.3 Global Vaccine Adjuvants Price by Type (2020-2025)
3.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Vaccine Adjuvants Sales Forecast by Type (2026-2031)
3.2.2 Global Vaccine Adjuvants Revenue Forecast by Type (2026-2031)
3.2.3 Global Vaccine Adjuvants Price Forecast by Type (2026-2031)
3.3 Different Types Vaccine Adjuvants Representative Players
4 Global Market Size by Application
4.1 Global Vaccine Adjuvants Historic Market Review by Application (2020-2025)
4.1.1 Global Vaccine Adjuvants Sales by Application (2020-2025)
4.1.2 Global Vaccine Adjuvants Revenue by Application (2020-2025)
4.1.3 Global Vaccine Adjuvants Price by Application (2020-2025)
4.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Vaccine Adjuvants Sales Forecast by Application (2026-2031)
4.2.2 Global Vaccine Adjuvants Revenue Forecast by Application (2026-2031)
4.2.3 Global Vaccine Adjuvants Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Vaccine Adjuvants Application
5 Competition Landscape by Players
5.1 Global Vaccine Adjuvants Sales by Players (2020-2025)
5.2 Global Top Vaccine Adjuvants Players by Revenue (2020-2025)
5.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2024)
5.4 Global Vaccine Adjuvants Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
5.7 Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Vaccine Adjuvants Sales by Company
6.1.1.1 North America Vaccine Adjuvants Sales by Company (2020-2025)
6.1.1.2 North America Vaccine Adjuvants Revenue by Company (2020-2025)
6.1.2 North America Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
6.1.3 North America Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
6.1.4 North America Vaccine Adjuvants Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Vaccine Adjuvants Sales by Company
6.2.1.1 Europe Vaccine Adjuvants Sales by Company (2020-2025)
6.2.1.2 Europe Vaccine Adjuvants Revenue by Company (2020-2025)
6.2.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
6.2.3 Europe Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
6.2.4 Europe Vaccine Adjuvants Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Vaccine Adjuvants Sales by Company
6.3.1.1 China Vaccine Adjuvants Sales by Company (2020-2025)
6.3.1.2 China Vaccine Adjuvants Revenue by Company (2020-2025)
6.3.2 China Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
6.3.3 China Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
6.3.4 China Vaccine Adjuvants Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 GSK
7.1.1 GSK Company Information
7.1.2 GSK Business Overview
7.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.1.4 GSK Vaccine Adjuvants Products Offered
7.1.5 GSK Recent Development
7.2 CSL Limited
7.2.1 CSL Limited Company Information
7.2.2 CSL Limited Business Overview
7.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.2.4 CSL Limited Vaccine Adjuvants Products Offered
7.2.5 CSL Limited Recent Development
7.3 Croda
7.3.1 Croda Company Information
7.3.2 Croda Business Overview
7.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Croda Vaccine Adjuvants Products Offered
7.3.5 Croda Recent Development
7.4 SEPPIC
7.4.1 SEPPIC Company Information
7.4.2 SEPPIC Business Overview
7.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.4.4 SEPPIC Vaccine Adjuvants Products Offered
7.4.5 SEPPIC Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Sanofi Vaccine Adjuvants Products Offered
7.5.5 Sanofi Recent Development
7.6 Zhifei Biological
7.6.1 Zhifei Biological Company Information
7.6.2 Zhifei Biological Business Overview
7.6.3 Zhifei Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Zhifei Biological Vaccine Adjuvants Products Offered
7.6.5 Zhifei Biological Recent Development
7.7 Escon
7.7.1 Escon Company Information
7.7.2 Escon Business Overview
7.7.3 Escon Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Escon Vaccine Adjuvants Products Offered
7.7.5 Escon Recent Development
7.8 Huanuotai Biological
7.8.1 Huanuotai Biological Company Information
7.8.2 Huanuotai Biological Business Overview
7.8.3 Huanuotai Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Huanuotai Biological Vaccine Adjuvants Products Offered
7.8.5 Huanuotai Biological Recent Development
7.9 Rico Bio
7.9.1 Rico Bio Company Information
7.9.2 Rico Bio Business Overview
7.9.3 Rico Bio Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Rico Bio Vaccine Adjuvants Products Offered
7.9.5 Rico Bio Recent Development
7.10 SDA BIO
7.10.1 SDA BIO Company Information
7.10.2 SDA BIO Business Overview
7.10.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.10.4 SDA BIO Vaccine Adjuvants Products Offered
7.10.5 SDA BIO Recent Development
7.11 SPI Pharma
7.11.1 SPI Pharma Company Information
7.11.2 SPI Pharma Business Overview
7.11.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.11.4 SPI Pharma Vaccine Adjuvants Products Offered
7.11.5 SPI Pharma Recent Development
7.12 Phibro Animal Health
7.12.1 Phibro Animal Health Company Information
7.12.2 Phibro Animal Health Business Overview
7.12.3 Phibro Animal Health Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Phibro Animal Health Vaccine Adjuvants Products Offered
7.12.5 Phibro Animal Health Recent Development
7.13 Vertellus
7.13.1 Vertellus Company Information
7.13.2 Vertellus Business Overview
7.13.3 Vertellus Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Vertellus Vaccine Adjuvants Products Offered
7.13.5 Vertellus Recent Development
8 Vaccine Adjuvants Manufacturing Cost Analysis
8.1 Vaccine Adjuvants Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Vaccine Adjuvants
8.4 Vaccine Adjuvants Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Vaccine Adjuvants Distributors List
9.3 Vaccine Adjuvants Customers
10 Vaccine Adjuvants Market Dynamics
10.1 Vaccine Adjuvants Industry Trends
10.2 Vaccine Adjuvants Market Drivers
10.3 Vaccine Adjuvants Market Challenges
10.4 Vaccine Adjuvants Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Vaccine Adjuvants Product Scope
1.2 Vaccine Adjuvants by Type
1.2.1 Global Vaccine Adjuvants Sales by Type (2020 & 2024 & 2031)
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Vaccine Adjuvants by Application
1.3.1 Global Vaccine Adjuvants Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Global Vaccine Adjuvants Market Estimates and Forecasts (2020-2031)
1.4.1 Global Vaccine Adjuvants Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Vaccine Adjuvants Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Vaccine Adjuvants Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Vaccine Adjuvants Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Vaccine Adjuvants Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Vaccine Adjuvants Sales Market Share by Region (2020-2025)
2.2.2 Global Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
2.3 Global Vaccine Adjuvants Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Vaccine Adjuvants Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Vaccine Adjuvants Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Vaccine Adjuvants Market Size and Prospective (2020-2031)
2.4.2 Europe Vaccine Adjuvants Market Size and Prospective (2020-2031)
2.4.3 China Vaccine Adjuvants Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Vaccine Adjuvants Historic Market Review by Type (2020-2025)
3.1.1 Global Vaccine Adjuvants Sales by Type (2020-2025)
3.1.2 Global Vaccine Adjuvants Revenue by Type (2020-2025)
3.1.3 Global Vaccine Adjuvants Price by Type (2020-2025)
3.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Vaccine Adjuvants Sales Forecast by Type (2026-2031)
3.2.2 Global Vaccine Adjuvants Revenue Forecast by Type (2026-2031)
3.2.3 Global Vaccine Adjuvants Price Forecast by Type (2026-2031)
3.3 Different Types Vaccine Adjuvants Representative Players
4 Global Market Size by Application
4.1 Global Vaccine Adjuvants Historic Market Review by Application (2020-2025)
4.1.1 Global Vaccine Adjuvants Sales by Application (2020-2025)
4.1.2 Global Vaccine Adjuvants Revenue by Application (2020-2025)
4.1.3 Global Vaccine Adjuvants Price by Application (2020-2025)
4.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Vaccine Adjuvants Sales Forecast by Application (2026-2031)
4.2.2 Global Vaccine Adjuvants Revenue Forecast by Application (2026-2031)
4.2.3 Global Vaccine Adjuvants Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Vaccine Adjuvants Application
5 Competition Landscape by Players
5.1 Global Vaccine Adjuvants Sales by Players (2020-2025)
5.2 Global Top Vaccine Adjuvants Players by Revenue (2020-2025)
5.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2024)
5.4 Global Vaccine Adjuvants Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
5.7 Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Vaccine Adjuvants Sales by Company
6.1.1.1 North America Vaccine Adjuvants Sales by Company (2020-2025)
6.1.1.2 North America Vaccine Adjuvants Revenue by Company (2020-2025)
6.1.2 North America Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
6.1.3 North America Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
6.1.4 North America Vaccine Adjuvants Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Vaccine Adjuvants Sales by Company
6.2.1.1 Europe Vaccine Adjuvants Sales by Company (2020-2025)
6.2.1.2 Europe Vaccine Adjuvants Revenue by Company (2020-2025)
6.2.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
6.2.3 Europe Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
6.2.4 Europe Vaccine Adjuvants Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Vaccine Adjuvants Sales by Company
6.3.1.1 China Vaccine Adjuvants Sales by Company (2020-2025)
6.3.1.2 China Vaccine Adjuvants Revenue by Company (2020-2025)
6.3.2 China Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
6.3.3 China Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
6.3.4 China Vaccine Adjuvants Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 GSK
7.1.1 GSK Company Information
7.1.2 GSK Business Overview
7.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.1.4 GSK Vaccine Adjuvants Products Offered
7.1.5 GSK Recent Development
7.2 CSL Limited
7.2.1 CSL Limited Company Information
7.2.2 CSL Limited Business Overview
7.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.2.4 CSL Limited Vaccine Adjuvants Products Offered
7.2.5 CSL Limited Recent Development
7.3 Croda
7.3.1 Croda Company Information
7.3.2 Croda Business Overview
7.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Croda Vaccine Adjuvants Products Offered
7.3.5 Croda Recent Development
7.4 SEPPIC
7.4.1 SEPPIC Company Information
7.4.2 SEPPIC Business Overview
7.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.4.4 SEPPIC Vaccine Adjuvants Products Offered
7.4.5 SEPPIC Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Sanofi Vaccine Adjuvants Products Offered
7.5.5 Sanofi Recent Development
7.6 Zhifei Biological
7.6.1 Zhifei Biological Company Information
7.6.2 Zhifei Biological Business Overview
7.6.3 Zhifei Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Zhifei Biological Vaccine Adjuvants Products Offered
7.6.5 Zhifei Biological Recent Development
7.7 Escon
7.7.1 Escon Company Information
7.7.2 Escon Business Overview
7.7.3 Escon Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Escon Vaccine Adjuvants Products Offered
7.7.5 Escon Recent Development
7.8 Huanuotai Biological
7.8.1 Huanuotai Biological Company Information
7.8.2 Huanuotai Biological Business Overview
7.8.3 Huanuotai Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Huanuotai Biological Vaccine Adjuvants Products Offered
7.8.5 Huanuotai Biological Recent Development
7.9 Rico Bio
7.9.1 Rico Bio Company Information
7.9.2 Rico Bio Business Overview
7.9.3 Rico Bio Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Rico Bio Vaccine Adjuvants Products Offered
7.9.5 Rico Bio Recent Development
7.10 SDA BIO
7.10.1 SDA BIO Company Information
7.10.2 SDA BIO Business Overview
7.10.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.10.4 SDA BIO Vaccine Adjuvants Products Offered
7.10.5 SDA BIO Recent Development
7.11 SPI Pharma
7.11.1 SPI Pharma Company Information
7.11.2 SPI Pharma Business Overview
7.11.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.11.4 SPI Pharma Vaccine Adjuvants Products Offered
7.11.5 SPI Pharma Recent Development
7.12 Phibro Animal Health
7.12.1 Phibro Animal Health Company Information
7.12.2 Phibro Animal Health Business Overview
7.12.3 Phibro Animal Health Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Phibro Animal Health Vaccine Adjuvants Products Offered
7.12.5 Phibro Animal Health Recent Development
7.13 Vertellus
7.13.1 Vertellus Company Information
7.13.2 Vertellus Business Overview
7.13.3 Vertellus Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Vertellus Vaccine Adjuvants Products Offered
7.13.5 Vertellus Recent Development
8 Vaccine Adjuvants Manufacturing Cost Analysis
8.1 Vaccine Adjuvants Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Vaccine Adjuvants
8.4 Vaccine Adjuvants Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Vaccine Adjuvants Distributors List
9.3 Vaccine Adjuvants Customers
10 Vaccine Adjuvants Market Dynamics
10.1 Vaccine Adjuvants Industry Trends
10.2 Vaccine Adjuvants Market Drivers
10.3 Vaccine Adjuvants Market Challenges
10.4 Vaccine Adjuvants Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Vaccine Adjuvants Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Vaccine Adjuvants Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Vaccine Adjuvants Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Vaccine Adjuvants Sales (MT) by Region (2020-2025)
Table 5. Global Vaccine Adjuvants Sales Market Share by Region (2020-2025)
Table 6. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Vaccine Adjuvants Revenue Share by Region (2020-2025)
Table 8. Global Vaccine Adjuvants Sales (MT) Forecast by Region (2026-2031)
Table 9. Global Vaccine Adjuvants Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Vaccine Adjuvants Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Vaccine Adjuvants Revenue Share Forecast by Region (2026-2031)
Table 12. Global Vaccine Adjuvants Sales by Type (MT) & (2020-2025)
Table 13. Global Vaccine Adjuvants Sales Share by Type (2020-2025)
Table 14. Global Vaccine Adjuvants Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Vaccine Adjuvants Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Vaccine Adjuvants Sales by Type (MT) & (2026-2031)
Table 17. Global Vaccine Adjuvants Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Vaccine Adjuvants Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Vaccine Adjuvants Sales by Application (MT) & (2020-2025)
Table 21. Global Vaccine Adjuvants Sales Share by Application (2020-2025)
Table 22. Global Vaccine Adjuvants Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Vaccine Adjuvants Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Vaccine Adjuvants Sales by Application (MT) & (2026-2031)
Table 25. Global Vaccine Adjuvants Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Vaccine Adjuvants Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Vaccine Adjuvants Application
Table 28. Global Vaccine Adjuvants Sales by Company (MT) & (2020-2025)
Table 29. Global Vaccine Adjuvants Sales Share by Company (2020-2025)
Table 30. Global Vaccine Adjuvants Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Vaccine Adjuvants Revenue Share by Company (2020-2025)
Table 32. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2024)
Table 33. Global Market Vaccine Adjuvants Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
Table 36. Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 39. North America Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 40. North America Vaccine Adjuvants Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 42. North America Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 43. North America Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 44. North America Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 45. North America Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 46. Europe Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 47. Europe Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 48. Europe Vaccine Adjuvants Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 50. Europe Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 51. Europe Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 52. Europe Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 53. Europe Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 54. China Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 55. China Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 56. China Vaccine Adjuvants Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 58. China Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 59. China Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 60. China Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 61. China Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 62. GSK Company Information
Table 63. GSK Description and Business Overview
Table 64. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 65. GSK Vaccine Adjuvants Product
Table 66. GSK Recent Development
Table 67. CSL Limited Company Information
Table 68. CSL Limited Description and Business Overview
Table 69. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 70. CSL Limited Vaccine Adjuvants Product
Table 71. CSL Limited Recent Development
Table 72. Croda Company Information
Table 73. Croda Description and Business Overview
Table 74. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Croda Vaccine Adjuvants Product
Table 76. Croda Recent Development
Table 77. SEPPIC Company Information
Table 78. SEPPIC Description and Business Overview
Table 79. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. SEPPIC Vaccine Adjuvants Product
Table 81. SEPPIC Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Sanofi Vaccine Adjuvants Product
Table 86. Sanofi Recent Development
Table 87. Zhifei Biological Company Information
Table 88. Zhifei Biological Description and Business Overview
Table 89. Zhifei Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Zhifei Biological Vaccine Adjuvants Product
Table 91. Zhifei Biological Recent Development
Table 92. Escon Company Information
Table 93. Escon Description and Business Overview
Table 94. Escon Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Escon Vaccine Adjuvants Product
Table 96. Escon Recent Development
Table 97. Huanuotai Biological Company Information
Table 98. Huanuotai Biological Description and Business Overview
Table 99. Huanuotai Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Huanuotai Biological Vaccine Adjuvants Product
Table 101. Huanuotai Biological Recent Development
Table 102. Rico Bio Company Information
Table 103. Rico Bio Description and Business Overview
Table 104. Rico Bio Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Rico Bio Vaccine Adjuvants Product
Table 106. Rico Bio Recent Development
Table 107. SDA BIO Company Information
Table 108. SDA BIO Description and Business Overview
Table 109. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. SDA BIO Vaccine Adjuvants Product
Table 111. SDA BIO Recent Development
Table 112. SPI Pharma Company Information
Table 113. SPI Pharma Description and Business Overview
Table 114. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. SPI Pharma Vaccine Adjuvants Product
Table 116. SPI Pharma Recent Development
Table 117. Phibro Animal Health Company Information
Table 118. Phibro Animal Health Description and Business Overview
Table 119. Phibro Animal Health Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Phibro Animal Health Vaccine Adjuvants Product
Table 121. Phibro Animal Health Recent Development
Table 122. Vertellus Company Information
Table 123. Vertellus Description and Business Overview
Table 124. Vertellus Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Vertellus Vaccine Adjuvants Product
Table 126. Vertellus Recent Development
Table 127. Production Base and Market Concentration Rate of Raw Material
Table 128. Key Suppliers of Raw Materials
Table 129. Vaccine Adjuvants Distributors List
Table 130. Vaccine Adjuvants Customers List
Table 131. Vaccine Adjuvants Market Trends
Table 132. Vaccine Adjuvants Market Drivers
Table 133. Vaccine Adjuvants Market Challenges
Table 134. Vaccine Adjuvants Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Vaccine Adjuvants Sales Market Share by Type in 2024 & 2031
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccine Adjuvants Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Vaccine Adjuvants Sales Market Share by Application in 2024 & 2031
Figure 9. Human Vaccine Examples
Figure 10. Veterinary Vaccine Examples
Figure 11. Global Vaccine Adjuvants Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vaccine Adjuvants Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 14. Global Vaccine Adjuvants Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 15. Vaccine Adjuvants Report Years Considered
Figure 16. Global Market Vaccine Adjuvants Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Vaccine Adjuvants Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 20. Europe Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 22. China Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 24. Global Vaccine Adjuvants Revenue Share by Type (2020-2025)
Figure 25. Global Vaccine Adjuvants Sales Share by Type (2026-2031)
Figure 26. Global Vaccine Adjuvants Revenue Share by Type (2026-2031)
Figure 27. Global Vaccine Adjuvants Revenue Share by Application (2020-2025)
Figure 28. Global Vaccine Adjuvants Revenue Growth Rate by Application in 2020 & 2024
Figure 29. Global Vaccine Adjuvants Sales Share by Application (2026-2031)
Figure 30. Global Vaccine Adjuvants Revenue Share by Application (2026-2031)
Figure 31. Global Vaccine Adjuvants Sales Share by Company (2024)
Figure 32. Global Vaccine Adjuvants Revenue Share by Company (2024)
Figure 33. Global 5 Largest Vaccine Adjuvants Players Market Share by Revenue in Vaccine Adjuvants: 2020 & 2024
Figure 34. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 35. Manufacturing Cost Structure of Vaccine Adjuvants
Figure 36. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 37. Vaccine Adjuvants Industrial Chain
Figure 38. Channels of Distribution (Direct Vs Distribution)
Figure 39. Distributors Profiles
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
Table 1. Global Vaccine Adjuvants Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Vaccine Adjuvants Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Vaccine Adjuvants Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Vaccine Adjuvants Sales (MT) by Region (2020-2025)
Table 5. Global Vaccine Adjuvants Sales Market Share by Region (2020-2025)
Table 6. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Vaccine Adjuvants Revenue Share by Region (2020-2025)
Table 8. Global Vaccine Adjuvants Sales (MT) Forecast by Region (2026-2031)
Table 9. Global Vaccine Adjuvants Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Vaccine Adjuvants Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Vaccine Adjuvants Revenue Share Forecast by Region (2026-2031)
Table 12. Global Vaccine Adjuvants Sales by Type (MT) & (2020-2025)
Table 13. Global Vaccine Adjuvants Sales Share by Type (2020-2025)
Table 14. Global Vaccine Adjuvants Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Vaccine Adjuvants Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Vaccine Adjuvants Sales by Type (MT) & (2026-2031)
Table 17. Global Vaccine Adjuvants Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Vaccine Adjuvants Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Vaccine Adjuvants Sales by Application (MT) & (2020-2025)
Table 21. Global Vaccine Adjuvants Sales Share by Application (2020-2025)
Table 22. Global Vaccine Adjuvants Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Vaccine Adjuvants Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Vaccine Adjuvants Sales by Application (MT) & (2026-2031)
Table 25. Global Vaccine Adjuvants Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Vaccine Adjuvants Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Vaccine Adjuvants Application
Table 28. Global Vaccine Adjuvants Sales by Company (MT) & (2020-2025)
Table 29. Global Vaccine Adjuvants Sales Share by Company (2020-2025)
Table 30. Global Vaccine Adjuvants Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Vaccine Adjuvants Revenue Share by Company (2020-2025)
Table 32. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2024)
Table 33. Global Market Vaccine Adjuvants Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
Table 36. Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 39. North America Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 40. North America Vaccine Adjuvants Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 42. North America Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 43. North America Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 44. North America Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 45. North America Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 46. Europe Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 47. Europe Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 48. Europe Vaccine Adjuvants Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 50. Europe Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 51. Europe Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 52. Europe Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 53. Europe Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 54. China Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 55. China Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 56. China Vaccine Adjuvants Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 58. China Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 59. China Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 60. China Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 61. China Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 62. GSK Company Information
Table 63. GSK Description and Business Overview
Table 64. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 65. GSK Vaccine Adjuvants Product
Table 66. GSK Recent Development
Table 67. CSL Limited Company Information
Table 68. CSL Limited Description and Business Overview
Table 69. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 70. CSL Limited Vaccine Adjuvants Product
Table 71. CSL Limited Recent Development
Table 72. Croda Company Information
Table 73. Croda Description and Business Overview
Table 74. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Croda Vaccine Adjuvants Product
Table 76. Croda Recent Development
Table 77. SEPPIC Company Information
Table 78. SEPPIC Description and Business Overview
Table 79. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. SEPPIC Vaccine Adjuvants Product
Table 81. SEPPIC Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Sanofi Vaccine Adjuvants Product
Table 86. Sanofi Recent Development
Table 87. Zhifei Biological Company Information
Table 88. Zhifei Biological Description and Business Overview
Table 89. Zhifei Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Zhifei Biological Vaccine Adjuvants Product
Table 91. Zhifei Biological Recent Development
Table 92. Escon Company Information
Table 93. Escon Description and Business Overview
Table 94. Escon Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Escon Vaccine Adjuvants Product
Table 96. Escon Recent Development
Table 97. Huanuotai Biological Company Information
Table 98. Huanuotai Biological Description and Business Overview
Table 99. Huanuotai Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Huanuotai Biological Vaccine Adjuvants Product
Table 101. Huanuotai Biological Recent Development
Table 102. Rico Bio Company Information
Table 103. Rico Bio Description and Business Overview
Table 104. Rico Bio Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Rico Bio Vaccine Adjuvants Product
Table 106. Rico Bio Recent Development
Table 107. SDA BIO Company Information
Table 108. SDA BIO Description and Business Overview
Table 109. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. SDA BIO Vaccine Adjuvants Product
Table 111. SDA BIO Recent Development
Table 112. SPI Pharma Company Information
Table 113. SPI Pharma Description and Business Overview
Table 114. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. SPI Pharma Vaccine Adjuvants Product
Table 116. SPI Pharma Recent Development
Table 117. Phibro Animal Health Company Information
Table 118. Phibro Animal Health Description and Business Overview
Table 119. Phibro Animal Health Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Phibro Animal Health Vaccine Adjuvants Product
Table 121. Phibro Animal Health Recent Development
Table 122. Vertellus Company Information
Table 123. Vertellus Description and Business Overview
Table 124. Vertellus Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Vertellus Vaccine Adjuvants Product
Table 126. Vertellus Recent Development
Table 127. Production Base and Market Concentration Rate of Raw Material
Table 128. Key Suppliers of Raw Materials
Table 129. Vaccine Adjuvants Distributors List
Table 130. Vaccine Adjuvants Customers List
Table 131. Vaccine Adjuvants Market Trends
Table 132. Vaccine Adjuvants Market Drivers
Table 133. Vaccine Adjuvants Market Challenges
Table 134. Vaccine Adjuvants Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Vaccine Adjuvants Sales Market Share by Type in 2024 & 2031
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccine Adjuvants Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Vaccine Adjuvants Sales Market Share by Application in 2024 & 2031
Figure 9. Human Vaccine Examples
Figure 10. Veterinary Vaccine Examples
Figure 11. Global Vaccine Adjuvants Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vaccine Adjuvants Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 14. Global Vaccine Adjuvants Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 15. Vaccine Adjuvants Report Years Considered
Figure 16. Global Market Vaccine Adjuvants Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Vaccine Adjuvants Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 20. Europe Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 22. China Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Vaccine Adjuvants Sales (MT) Growth Rate (2020-2031)
Figure 24. Global Vaccine Adjuvants Revenue Share by Type (2020-2025)
Figure 25. Global Vaccine Adjuvants Sales Share by Type (2026-2031)
Figure 26. Global Vaccine Adjuvants Revenue Share by Type (2026-2031)
Figure 27. Global Vaccine Adjuvants Revenue Share by Application (2020-2025)
Figure 28. Global Vaccine Adjuvants Revenue Growth Rate by Application in 2020 & 2024
Figure 29. Global Vaccine Adjuvants Sales Share by Application (2026-2031)
Figure 30. Global Vaccine Adjuvants Revenue Share by Application (2026-2031)
Figure 31. Global Vaccine Adjuvants Sales Share by Company (2024)
Figure 32. Global Vaccine Adjuvants Revenue Share by Company (2024)
Figure 33. Global 5 Largest Vaccine Adjuvants Players Market Share by Revenue in Vaccine Adjuvants: 2020 & 2024
Figure 34. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 35. Manufacturing Cost Structure of Vaccine Adjuvants
Figure 36. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 37. Vaccine Adjuvants Industrial Chain
Figure 38. Channels of Distribution (Direct Vs Distribution)
Figure 39. Distributors Profiles
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232